Zolbetuximab,oxaliplatin,capecitabine
astellas
['esophageal', 'gastroesophageal', 'gastric', 'astellas']
in a rapid oral session at #asco23 today, investigational data from our phase 3 trial in advanced gastric/gastroesophageal junction adenocarcinoma will be shared as a follow-up to the plenary session series in march. #gastriccancer
A pharma company dedicated to changing tomorrow by improving the health of people around the world. Tweets for U.S. audience. Guidelines: https://t.co/AJlgiDgp38